MANCHESTER - English Premier League leaders Manchester City signed a regional partnership deal with healthcare and pharmaceutical company, Mundipharma, which has its regional office in Singapore on Thursday (Sept 30).
The three-year agreement will see Mundipharma named as the football club's official healthcare product partner in the emerging markets. The logo for the company's range of Betadine medicines will be featured on the sleeves of City's medical staff at friendly matches in the Asia-Pacific, Latin America, the Middle East and Africa.
At a press conference at the Academy Stadium, a facility for the club's 400 youth players next to the Etihad Stadium, City's chief operating officer Omar Berrada said: "Their (Mundipharma) commitment to connecting with their in-market consumers in innovative and meaningful ways reflects that of Manchester City, making them a fitting partner for the club."
Mundipharma's president for the Asia-Pacific, Latin America, the Middle East and Africa markets Raman Singh, who is based in Singapore, added: "Sports reaches and inspires people around the world. We intend to harness this power to raise awareness on key health issues such as preventing the spread of infectious diseases, which is a major focus for us in emerging markets where there have been a number of recent outbreaks."
Apart from utilising the club's branding in the company's marketing and advertising campaigns, the logo of Mundipharma's Betadine range of medicines will feature on the sleeves of City's medical staff at friendly matches in the Asia-Pacific, Latin America, the Middle East and Africa.
In addition, the two parties will also collaborate to offer young fans from these emerging markets to travel to Manchester for training sessions at the City Football Academy.